All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the 63rd ASH Annual Meeting and Exposition, the GvHD Hub was pleased to speak to Guru Subramanian Guru Murthy, Medical College of Wisconsin, Milwaukee, US. We asked, how do pre-allo-HSCT conditioning regimens impact GvHD outcomes in myelofibrosis patients?
How do pre-allo-HSCT conditioning regimens impact GvHD outcomes in myelofibrosis patients?
In this video, Murthy discusses the factors that can be modified before transplant, including conditioning intensity and conditioning regimens. He also discusses the findings of his teams' study, which was conducted using the Center for International Blood and Marrow Transplant Research (CIBMTR) database, and included adults aged ≥18 years with the diagnosis of myelofibrosis who underwent allo-HSCT between 2009–2019. Lastly, he comments on the role of pre-transplant ruxolitinib.
Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract
Results from a retrospective study in Annals of Hematology demonstrated that ileostomy induced significant clinical responses in patients with...
IACH 2018 | Management of acute graft-versus-host disease
At IACH 2018, Professor Florent Malard, a member of the GvHD Hub Steering Committee, presented an educational talk on acute graft-versus-host disease management.
Subscribe to get the best content related to GvHD delivered to your inbox